Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
<i>Background and Objectives</i>: One of the most frequently mutated oncogenes in cancer belongs to the Ras family of proto-oncogenes, which encode distinct key signaling events. RAS gain-of-function mutations are present in ~30% of all human cancers, with KRAS being the most frequently mutated isof...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2021-09-01
|
| Seri Bilgileri: | Medicina |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/1648-9144/57/10/1039 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|